Summary
Better scientific understanding of cannabis effects and the development of treatments for cannabis dependence require clinical studies involving cannabis administration. Cannabis can be administered by smoking a plant-derived cigarette or by oral or intravenous administration of Δ9-tetrahydrocannabinol (THC), the primary psychoactive chemical in cannabis. The smoked route is most commonly used outside the laboratory, but is subject to wide variation in absorbed dose. Oral synthetic THC is a legally marketed medication (dronabinol), also subject to wide pharmacokinetic variation, but offering a greater safety margin because of slower onset of action and lower potency. Intravenous THC offers precise investigator control of dose and timing. Acute adverse effects of cannabis administration include tachycardia, orthostatic hypotension, pulmonary irritation (if smoked), motor incoordination, cognitive impairment, anxiety, paranoia, and psychosis. Screening of research subjects should identify and exclude those with risk factors for such events, e.g., a history of significant cardiovascular, pulmonary, or psychiatric disorders.
Monitoring of subjects during cannabis administration should include heart rate, blood pressure, and mental status. Subjects should not be discharged from research participation until reevaluation has shown that they have returned to baseline status.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
United Nations Office on Drugs and Crime. (2003) Global Illicit Drug Trends, 2003, United Nations Office on Drugs and Crime, New York.
Substance Abuse & Mental Health Services Administration. (2002) National Survey on Drug Use and Health, 2002, Substance Abuse & Mental Health Services Administration, Rockville MD.
McPartland J. M. and Pruitt P. L. (1999) Side effects of pharmaceuticals not elicited by comparable herbal medicines: the case of tetrahydrocannabinol and marijuana. Altern. Ther. Health Med. 5, 57–62.
College on Problems of Drug Dependence. (1995) Human subject issues in drug abuse research. College on Problems of Drug Dependence. Drug Alcohol Depend. 37, 167–175.
Fischman M. W. and Johanson C. E. (1998) Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers. Behav. Pharmacol. 9, 479–498.
Gorelick D. A., Pickens R., and Bonkovsky F. (1999) Clinical research in substance abuse: human subjects issues, in Ethics in Psychiatric Research: A Resource Manual for Human Subject Protection (Pincus, H. A., Lieberman, J. A., and Ferris, S., eds.) American Psychiatric Press, Washington, DC, pp. 177–218.
Miller F. G. and Rosenstein D. L. (1997) Psychiatric symptom-provoking studies: an ethical appraisal. Biol. Psychiatry. 42, 403–409.
Azorlosa J. L., Heishman S. J., Stitzer M. L., and Mahaffey J. M. (1992) Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs. J. Pharmacol Exp Ther. 261, 114–122.
Heishman S. J., Stitzer M., and Yingling J. E. (1989) Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacol Biochem. Behav. 34, 173–179.
Chait L. D. and Perry J. L. (1992) Factors influencing self-administration of, and subjective response to, placebo marijuana. Behav. Pharmacol. 3, 545–552.
Kirk J. M., Doty P., and de Wit H. (1998) Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 59, 287–293.
Chait L. D. and Pierri J. (1989) Some physical characteristics of NIDA marijuana cigarettes. Addict. Behav. 14,61–67.
Heishman S. J., Stitzer M. L., and Bigelow G. E. (1988) Alcohol and marijuana: comparative dose effect profiles in humans. Pharmacol. Biochem. Behav. 31, 649–655.
Cone, E. J., Johnson, R. E., Paul, B. D., Mell, L. D., and Mitchell, J. (1988) Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestion. J. Anal. Toxicol. 12, 169–175.
Mathew, R. J., Wilson, W. H., Turkington, T. G., and Coleman,R. E. (1998) Cerebellar activity and disturbed time sense after THC. Brain Res. 797,183–189.
Apseloff, G., Swayne, J. K., and Gerber, N. (1996) Medical histories may be unreliable in screening volunteers for clinical trials. Clin. Pharmacol. Ther. 60, 353–356.
Struve, F. A., Straumanis, J. J., Manno, J. E., Fitzgerald, M. J., Patrick, G., and Leavitt, J. (2000) Inadequacies of self-report data for exclusion criteria detection in marihuana research: an empirical case for multi-method direct examination screening. J. Addict. Dis. 19,71–87.
American Psychiatric Association. (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th text revision ed., American Psychiatric Association, Washington, DC.
Charland, L. C. (2002) Cynthia’s dilemma: consenting to heroin prescription. Am. J. Bioeth. 2,37–47.
Cohen, P. J. (2002) Untreated addiction imposes an ethical bar to recruiting addicts for non-therapeutic studies of addictive drugs. J. Law Med. Ethics 30, 73–81.
Ling, W. (2002) Cynthia’s dilemma. Am. J. Bioeth. 2, 55–56.
Huestis, M. A., Mitchell, J. M., and Cone, E. J. (1995) Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J. Anal. Toxicol. 19,443–449.
Verstraete, A. G. (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug Monit. 26, 200–205.
Chait, L. D., Fischman, M. W., and Schuster, C. R. (1985) ’Hangover’ effects the morning after marijuana smoking. Drug Alcohol Depend. 15, 229–238.
Huestis, M. A., Gorelick, D. A., Heishman, S. J., et al. (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch. Gen. Psychiatry 58,322–328.
Beardsley, P. M. and Kelly, T. H. (1999) Acute effects of cannabis on human behavior and central nervous system function, in The Health Effects of Cannabis (Kalant, H., Corrigall, W., Hall, W., and Smart, R., eds.), Addiction Research Foundation, Toronto, pp. 127–169.
Chait, L. D. and Pierri, J. (1992) Effects of smoked marijuana on human performance: a critical review, in Marijuana/Cannabinoids: Neurobiology and Neurophysiology (Murphy, L. and Bartke, A., eds.), CRC Press, Boca Raton, FL, pp. 387–424.
Heishman, S. J. and Myers, C. S. (2005) Effects of abused drugs on human performance: Laboratory assessment, in Drug Abuse Handbook (Karch S. B., ed.), CRC Press, Boca Raton, FL, in press.
Pope, H. G., Jr., Grube, A. J., and Yurgelun-Todd, D. (1995) The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend. 38, 25–34.
Heishman, S. J., Taylor, R. C., and Henningfield, J. E. (1994) Nicotine and smoking: a review of effects on human performance. Exp. Clin. Psychopharmacol. 2, 345–395.
Heishman, S. J., Huestis, M., Henningfield, J. E., and Cone, E. J. (1990) Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol. Biochem. Behav. 37, 561–565.
Jones, R. T. (2002) Cardiovascular system effects of marijuana. J. Clin. Pharmacol. 42, 58S–63S.
Prakash, R., Aronow, W. S., Warren, M., Laverty, W., and Gottschalk, L. A. (1975) Effects of marihuana and placebo marihuana smoking on hemodynamics in coronary disease. Clin. Pharmacol. Ther. 18, 90–95.
Renaud, A. M. and Cormier, Y. (1986) Acute effects of marihuana smoking on maximal exercise performance. Med. Sci. Sports Exerc. 18, 685–689.
Aronow, W. S. and Cassidy, J. (1974) Effect of marihuana and placebo-marihuana smoking on angina pectoris. N. Engl. J. Med. 291, 65–67.
Frishman, W. H., Del Vecchio, A., Sanal, S., and Ismail, A. (2003) Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Dis. 5, 253–271.
Selden, B. S., Clark, R. F., and Curry, S. C. (1990) Marijuana. Emerg. Med. Clin. North Am. 8, 527–539.
Wilkins, J. N., Mellott, K. G., Markvitsa, R., and Gorelick, D. A. (2003) Management of stimulant, hallucinogen, marijuana, phencyclidine, and club drug intoxication and withdrawal, in Principles of Addiction Medicine (Graham, A. W., Schultz, T. K., Mayo-Smith, M. F., Ries, R. K., and Wilford, B. B., eds.), American Society of Addiction Medicine, Chevy Chase, MD, pp. 671–695.
Mathew, R. J., Wilson, W. H., and Davis, R. (2003) Postural syncope after marijuana: a transcranial Doppler study of the hemodynamics. Pharmacol. Biochem. Behav. 75, 309–318.
Brust, J. C. M. (1998) Acute neurologic complications of drug and alcohol abuse. Neurol. Clin. North Am. 16, 503–519.
Macdonald, S., Anglin-Bodrug, K., Mann, R. E., Erickson, P., Hathaway, A., Chipman, M., and Rylett, M. (2003) Injury risk associated with cannabis and cocaine use. Drug Alcohol Depend. 72, 99–115.
Tashkin, D. P., Shapiro, B. J., and Frank, I. M. (1973) Acute pulmonary physiologic effects of smoked marijuana and oral Δ9-tetrahydrocannabinol in healthy young men. N. Engl. J. Med. 289, 336–341.
Tilles, D. S., Goldenheim, P. D., Johnson, D. C., Mendelson, J. H., Mello, N. K., and Hales C. A. (1986) Marijuana smoking as cause of reduction in single-breath carbon monoxide diffusing capacity. Am. J. Med. 80, 601–606.
Wu, T. C., Tashkin, D. P., Djahed, B., and Rose, J. E. (1988) Pulmonary hazards of smoking marijuana as compared with tobacco. N. Engl. J. Med. 318, 347–351.
Taylor, D. R., Fergusson, D. M., Milne, B. J., et al. (2002) A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 97, 1055–1061.
Hurlbut, K. M. (1991) Drug-induced psychoses. Emerg. Med. Clin. North Am. 9, 31–52.
Szuster, R. R., Pontius, E. B., and Campos, P. E. (1988) Marijuana sensitivity and panic anxiety. J. Clin. Psychiatry 49, 427–429.
Greenberg, H. S., Werness, S. A., Pugh, J. E., Andrus, R. O., Anderson, D. J., and Domino, E. F. (1994) Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Clin. Pharmacol. Ther. 55, 324–328.
Greenwald, M. K. and Stitzer, M. L. (2000) Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend. 59, 261–275.
Liguori, A., Gatto, C. P., and Robinson, J. H. (1998) Effects of marijuana on equilibrium, psychomotor performance, and simulated driving. Behav. Pharmacol. 9, 599–609.
Block, R. I., Farinpour, R., and Braverman, K. (1992) Acute effects of marijuana on cognition: relationships to chronic effects and smoking techniques. Pharmacol. Biochem. Behav. 43, 907–917.
Wilson, W. H., Ellinwood, E. H., Mathew, R. J., and Johnson, K. (1994) Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. Psychiatry Res. 51, 115–125.
Heishman, S. J., Arasteh, K., and Stitzer, M. L. (1997) Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacol. Biochem. Behav. 58, 93–101.
Hart, C. L., Ward, A. S., Haney, M., Comer, S. D., Foltin,R. W., and Fischman, M. W. (2002) Comparison of smoked marijuana and oral delta(9)-tetrahydrocannabinol in humans. Psychopharmacology (Berl.) 164, 407–415.
Kelly, T. H., Foltin, R. W., Emurian, C. S., and Fischman, M. W. (1993) Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J. Anal. Toxicol. 17, 264–272.
Kurzthaler, I., Hummer, M., Miller, C., et al. (1999) Effect of cannabis use on cognitive functions and driving ability. J. Clin. Psychiatry 60, 395–399.
Heishman, S. J., Singleton, E. G., and Crouch, D. J. (1996) Laboratory validation study of drug evaluation and classification program: ethanol, cocaine, and marijuana. J. Anal. Toxicol. 20, 468–483.
Heishman, S. J., Singleton, E. G., and Crouch, D. J. (1998) Laboratory validation study of drug evaluation and classification program: alprazolam, d-amphetamine, codeine, and marijuana. J. Anal. Toxicol. 22, 503–514.
Ramaekers, J. G., Robbe, H. W., and O’Hanlon, J. F. (2000) Marijuana, alcohol and actual driving performance. Hum. Psychopharmacol. 15, 551–558.
Curran, H. V., Brignell, C., Fletcher, S., Middleton, P., and Henry, J. (2002) Cognitive and subjective dose-response effects of acute oral delta 9-tetrahydro cannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl.) 164, 61–70.
Chen, K., Kandel, D. B., and Davies, M. (1997) Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. Drug Alcohol Depend. 46, 53–67.
Wagner, F. A. and Anthony, J. C. (2002) From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 26, 479–488.
Wilson, D. M., Peart, J., Martin, B. R., Bridgen, D. T., Byron, P. R., and Lichtman, A. H. (2002) Physiochemical and pharmacological characterization of a delta(9)-THC aerosol generated by a metered dose inhaler. Drug Alcohol Depend. 67, 259–267.
Gorelick, D. A. (1998) The rate hypothesis and agonist substitution approaches to cocaine abuse treatment. Adv. Pharmacol. 42, 995–997.
Brown, J., Kranzler, H. R., and Del Boca, F. K. (1992) Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity. Br. J. Addict. 87, 1013–1024.
Harrison, L. (1997) The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res. Monogr. 167, 17–36.
Martin, G. W., Wilkinson, D. A., and Kapur, B. M. (1988) Validation of self-reported cannabis use by urine analysis. Addict. Behav. 13,147–150.
Jasinski, D. R., Martin, W. R., and Sapira, J. D. (1968) Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone. Clin. Pharmacol. Ther. 9, 215–222.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Gorelick, D.A., Heishman, S.J. (2006). Methods for Clinical Research Involving Cannabis Administration. In: Onaivi, E.S. (eds) Marijuana and Cannabinoid Research. Methods In Molecular Medicine™, vol 123. Humana Press. https://doi.org/10.1385/1-59259-999-0:235
Download citation
DOI: https://doi.org/10.1385/1-59259-999-0:235
Publisher Name: Humana Press
Print ISBN: 978-1-58829-350-3
Online ISBN: 978-1-59259-999-8
eBook Packages: Springer Protocols